Priorities for improved management of acute rheumatic fever and rheumatic heart disease: analysis of cross-sectional continuous quality improvement data in Aboriginal primary healthcare centres in Australia
Judith M. Katzenellenbogen A B E , Daniela Bond-Smith A , Anna P. Ralph C , Mathilda Wilmot B , Julie Marsh B , Ross Bailie D and Veronica Matthews DA School of Population and Global Health, The University of Western Australia, 35 Stirling Highway, Perth, WA 6009, Australia. Email: daniela.bond-smith@uwa.edu.au
B Telethon Kids Institute, The University of Western Australia, Perth Children's Hospital, 15 Hospital Avenue, Nedlands, WA 6009, Australia. Email: mathilda.wilmot@gmail.com; julie.marsh@telethonkids.org.au
C Menzies School of Health Research, Charles Darwin University, Royal Darwin Hospital Campus, John Matthews Building (Building 58), Rocklands Drive, Casuarina, NT 0810, Australia. Email: anna.ralph@menzies.edu.au
D University Centre for Rural Health, University of Sydney, 61 Uralba Street, Lismore, NSW 2480, Australia. Email: ross.bailie@sydney.edu.au; veronica.matthews@sydney.edu.au
E Correponding author. Email: judith.katzenellenbogen@uwa.edu.au
Australian Health Review 44(2) 212-221 https://doi.org/10.1071/AH19132
Submitted: 20 June 2019 Accepted: 15 July 2019 Published: 29 November 2019
Journal Compilation © AHHA 2020 Open Access CC BY-NC-ND
Abstract
Objective This study investigated the delivery of guideline-recommended services for the management of acute rheumatic fever (ARF) and rheumatic heart disease (RHD) in Australian primary healthcare centres participating in the Audit and Best Practice for Chronic Disease (ABCD) National Research Partnership project.
Methods ARF and RHD clinical audit data were collected from 63 Aboriginal centres in four Australian jurisdictions using the ABCD ARF/RHD audit tool. Records of up to 30 patients treated for ARF and/or RHD were analysed per centre from the most recent audit conducted between 2009 and 2014. The main outcome measure was a quality of ARF and RHD care composite indicator consisting of nine best-practice service items.
Results Of 1081 patients, most were Indigenous (96%), female (61%), from the Northern Territory and Queensland (97%) and <25 years of age (49%). The composite indicator was highest in the 0–14 year age group (77% vs 65–67% in other age groups). Timely injections and provision of client education are important specific areas for improvement. Multiple regression showed age >15 years to be a significant negative factor for several care indicators, particularly for the delivery of long-acting antibiotic injections and specialist services in the 15–24 year age group.
Conclusions The results suggest that timely injection and patient education are priorities for managing ARF and RHD, particularly focusing on child-to-adult transition care.
What is known about the topic? The burden of rheumatic fever and RHD in some Aboriginal communities is among the highest documented globally. Guideline-adherent RHD prevention and management in primary health care (PHC) settings are critically important to reduce this burden. Continuous quality improvement (CQI) is a proven strategy to improve guideline adherence, using audit cycles and proactive engagement of PHC end users with their own data. Previously, such CQI strategies using a systems approach were shown to improve delivery of ARF and RHD care in six Aboriginal health services (three government and three community controlled).
What does this paper add? This paper focuses on the variation across age groups in the quality of ARF and/or RHD care according to nine quality of care indicators across 63 PHC centres serving the Aboriginal population in the Northern Territory, Queensland, South Australia and Western Australia. These new findings provide insight into difference in quality of care by life stage, indicating particular areas for improvement of the management of ARF and RHD at the PHC level, and can act as a baseline for monitoring of care quality for ARF and RHD into the future.
What are the implications for practitioners? Management plans and innovative strategies or systems for improving adherence need to be developed as a matter of urgency. PHC professionals need to closely monitor adherence to secondary prophylaxis at both the clinic and individual level. RHD priority status needs to be assigned and recorded as a tool to guide management. Systems strengthening needs to particularly target child-to-adult transition care. Practitioners are urged to keep a quick link to the RHDAustralia website to access resources and guidelines pertaining to ARF and RHD (https://www.rhdaustralia.org.au/arf-rhd-guideline, accessed 3 October 2019). CQI strategies can assist PHC centres to improve the care they provide to patients.
References
[1] Carapetis JR, Beaton A, Cunningham MW, Guilherme L, Karthikeyan G, Mayosi BM, Sable C, Steer A, Wilson N, Wyber R, Zuhlke L. Acute rheumatic fever and rheumatic heart disease. Nat Rev Dis Primers 2016; 2 15084| Acute rheumatic fever and rheumatic heart disease.Crossref | GoogleScholarGoogle Scholar | 27188830PubMed |
[2] Australian Institute of Health and Welfare (AIHW). Rheumatic heart disease and acute rheumatic fever in Australia: 1996–2012. Canberra: AIHW; 2013.
[3] Australian Institute of Health and Welfare (AIHW). Australian burden of disease study: impact and causes of illness and death in Aboriginal and Torres Strait Islander people 2011. Canberra: AIHW; 2016.
[4] National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand. The Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease (2nd edition). 2012. Available at: https://www.rhdaustralia.org.au/sites/default/files/resources/quick_reference_guides_0.pdf [verified 3 October 2019].
[5] Centre for Remote Health. CARPA standard treatment manual, 7th edn. Alice Springs: Centre for Remote Health; 2017. Available at: https://docs.remotephcmanuals.com.au/review/g/manuals2017-manuals/d/20318.html?page=1 [verified 27 September 2019].
[6] Antibiotic Expert Group. Therapeutic guidelines: antibiotic. Melbourne: Therapeutic Guidelines Limited; 2014.
[7] Rheumatology Expert Group. Therapeutic guidelines: rheumatology, 3rd edn. Melbourne: Therapeutic Guidelines Limited; 2017.
[8] Gramenz E. Rheumatic heart disease going undiagnosed by NT’s fly-in doctors, cardiologist warns. ABC News 3 October 2018. Available at: https://www.abc.net.au/news/2018-09-30/rheumatic-heart-disease-awareness-interstate-doctors-nt/10320902 [verified 27 September 2019].
[9] Ralph AP, de Dassel JL, Kirby A, Read C, Mitchell AG, Maguire GP, Currie BJ, Bailie R, Johnston V, Carapetis JR. Improving delivery of secondary prophylaxis for rheumatic heart disease in a high-burden setting: outcome of a stepped-wedge, community, randomized trial. J Am Heart Assoc 2018; 7 e009308
| Improving delivery of secondary prophylaxis for rheumatic heart disease in a high-burden setting: outcome of a stepped-wedge, community, randomized trial.Crossref | GoogleScholarGoogle Scholar | 30561268PubMed |
[10] Russell DJ, Zhao Y, Guthridge S, Ramjan M, Jones MP, Humphreys JS, Wakerman J. Patterns of resident health workforce turnover and retention in remote communities of the Northern Territory of Australia, 2013–2015. Hum Resour Health 2017; 15 52
| Patterns of resident health workforce turnover and retention in remote communities of the Northern Territory of Australia, 2013–2015.Crossref | GoogleScholarGoogle Scholar | 28810919PubMed |
[11] Read C, Mitchell AG, de Dassel JL, Scrine C, Hendrickx D, Bailie RS, Johnston V, Maguire GP, Schultz R, Carapetis JR, Ralph AP. Qualitative evaluation of a complex intervention to improve rheumatic heart disease secondary prophylaxis. J Am Heart Assoc 2018; 7 e009376
| Qualitative evaluation of a complex intervention to improve rheumatic heart disease secondary prophylaxis.Crossref | GoogleScholarGoogle Scholar | 30018166PubMed |
[12] Ralph AP, Fittock M, Schultz R, Thompson D, Dowden M, Clemens T, Parnaby MG, Clark M, McDonald MI, Edwards KN, Carapetis JR, Bailie RS. Improvement in rheumatic fever and rheumatic heart disease management and prevention using a health centre-based continuous quality improvement approach. BMC Health Serv Res 2013; 13 525
| Improvement in rheumatic fever and rheumatic heart disease management and prevention using a health centre-based continuous quality improvement approach.Crossref | GoogleScholarGoogle Scholar | 24350582PubMed |
[13] Burgess CP, Sinclair G, Ramjan M, Coffey PJ, Connors CM, Katekar LV. Strengthening cardiovascular disease prevention in remote indigenous communities in Australia’s Northern Territory. Heart Lung Circ 2015; 24 450–7.
| Strengthening cardiovascular disease prevention in remote indigenous communities in Australia’s Northern Territory.Crossref | GoogleScholarGoogle Scholar | 25541229PubMed |
[14] Matthews V, Schierhout G, McBroom J, Connors C, Kennedy C, Kwedza R, Larkins S, Moore E, Thompson S, Scrimgeour D, Bailie R. Duration of participation in continuous quality improvement: a key factor explaining improved delivery of type 2 diabetes services. BMC Health Serv Res 2014; 14 578
| Duration of participation in continuous quality improvement: a key factor explaining improved delivery of type 2 diabetes services.Crossref | GoogleScholarGoogle Scholar | 25408165PubMed |
[15] Panaretto KS, Wenitong M, Button S, Ring IT. Aboriginal community controlled health services: leading the way in primary care. Med J Aust 2014; 200 649–52.
| Aboriginal community controlled health services: leading the way in primary care.Crossref | GoogleScholarGoogle Scholar | 24938346PubMed |
[16] Bailie R, Si D, Shannon C, Semmens J, Rowley K, Scrimgeour DJ, Nagel T, Anderson I, Connors C, Weeramanthri T, Thompson S, McDermott R, Burke H, Moore E, Leon D, Weston R, Gorgan H, Stanley A, Gardner K. Study protocol: national research partnership to improve primary health care performance and outcomes for Indigenous peoples. BMC Health Serv Res 2010; 10 129
| Study protocol: national research partnership to improve primary health care performance and outcomes for Indigenous peoples.Crossref | GoogleScholarGoogle Scholar | 20482810PubMed |
[17] One21seventy National Centre for Quality Improvement in Indigenous Primary Health Care. Acute rheumatic fever and rheumatic heart disease clinical audit protocol: 2013 release. Darwin: Menzies School of Health Research; 2013. Available at: https://www.menzies.edu.au/icms_docs/253288_Acute_rheumatic_fever_and_rheumatic_heart_disease_clinical_audit_protocol.pdf [verified 3 October 2019].
[18] Roberts K, Cannon J, Atkinson D, Brown A, Maguire G, Remenyi B, Wheaton G, Geelhoed E, Carapetis JR. Echocardiographic screening for rheumatic heart disease in Indigenous Australian children: a cost-utility analysis. J Am Heart Assoc 2017; 6 e004515
| Echocardiographic screening for rheumatic heart disease in Indigenous Australian children: a cost-utility analysis.Crossref | GoogleScholarGoogle Scholar | 28255077PubMed |
[19] Edwards K. Days at risk for acute rheumatic fever recurrence. NT Disease Control Bulletin 2013; 20 24–6.
[20] Eissa S, Lee R, Binns P, Garstone G, McDonald M. Assessment of a register-based rheumatic heart disease secondary prevention program in an Australian Aboriginal community. Aust N Z J Public Health 2005; 29 521–5.
| Assessment of a register-based rheumatic heart disease secondary prevention program in an Australian Aboriginal community.Crossref | GoogleScholarGoogle Scholar | 16366062PubMed |
[21] Mitchell AG, Belton S, Johnston V, Ralph AP. Transition to adult care for Aboriginal children with rheumatic fever: a review informed by a focussed ethnography in northern Australia. Aust J Prim Health 2018; 24 9–13.
| Transition to adult care for Aboriginal children with rheumatic fever: a review informed by a focussed ethnography in northern Australia.Crossref | GoogleScholarGoogle Scholar | 29310752PubMed |
[22] Holland JV, Hardie K, de Dassel J, Ralph AP. Rheumatic heart disease prophylaxis in older patients: a register-based audit of adherence to guidelines. Open Forum Infect Dis 2018; 5 ofy125
| Rheumatic heart disease prophylaxis in older patients: a register-based audit of adherence to guidelines.Crossref | GoogleScholarGoogle Scholar | 29942824PubMed |
[23] Mitchell AG, Belton S, Johnston V, Gondarra W, Ralph AP. ‘That heart sickness’: young Aboriginal people’s understanding of rheumatic fever. Med Anthropol 2019; 38 1–14.
| 30067382PubMed |
[24] RHD Australia. Resources. 2018. Available at: https://www.rhdaustralia.org.au/resources [verified 3 October 2019].
[25] Coffey PM, Ralph AP, Krause VL. The role of social determinants of health in the risk and prevention of Group A streptococcal infection, acute rheumatic fever and rheumatic heart disease: a systematic review. PLoS Negl Trop Dis 2018; 12 e0006577
| The role of social determinants of health in the risk and prevention of Group A streptococcal infection, acute rheumatic fever and rheumatic heart disease: a systematic review.Crossref | GoogleScholarGoogle Scholar | 29897915PubMed |
[26] Cannon JW, Jack S, Wu Y, Zhang J, Baker MG, Geelhoed E, Fraser J, Carapetis JR. An economic case for a vaccine to prevent Group A streptococcus skin infections. Vaccine 2018; 36 6968–78.
| An economic case for a vaccine to prevent Group A streptococcus skin infections.Crossref | GoogleScholarGoogle Scholar | 30340879PubMed |
[27] Wyber R, Katzenellenbogen JM, Pearson G, Gannon M. The rationale for action to end new cases of rheumatic heart disease in Australia. Med J Aust 2017; 207 322–3.
| The rationale for action to end new cases of rheumatic heart disease in Australia.Crossref | GoogleScholarGoogle Scholar | 29020895PubMed |
[28] Schierhout G, Hains J, Si D, C K, Cox R, Kwedza R, O’Donoghue L, Fittock M, Brands J, Lonergan K, Dowden M, Bailie R. Evaluating the effectiveness of a multifaceted, multilevel continuous quality improvement program in primary health care: developing a realist theory of change. Implement Sci 2013; 8 119
| Evaluating the effectiveness of a multifaceted, multilevel continuous quality improvement program in primary health care: developing a realist theory of change.Crossref | GoogleScholarGoogle Scholar | 24098940PubMed |
[29] de Dassel JL, Fittock MT, Wilks SC, Poole JE, Carapetis JR, Ralph AP. Adherence to secondary prophylaxis for rheumatic heart disease is underestimated by register data. PLoS One 2017; 12 e0178264
| Adherence to secondary prophylaxis for rheumatic heart disease is underestimated by register data.Crossref | GoogleScholarGoogle Scholar | 28562621PubMed |
[30] Katzenellenbogen JM, Bond-Smith D, Cunneen R, Dempsey K, Cannon J, Stacey I, Nedkoff L, Sanfilippo FM, Ralph AP, De Klerk N, Hung J, Geelhoed E, Williamson D, Wyber R, Bessarab D. The End Rheumatic Heart Disease in Australia Study of Epidemiology (ERASE) Project: data sources, case ascertainment and cohort profile. Clin Epidemiol 2019; in press
| The End Rheumatic Heart Disease in Australia Study of Epidemiology (ERASE) Project: data sources, case ascertainment and cohort profile.Crossref | GoogleScholarGoogle Scholar |
